Publication | Open Access
Targeted Therapy of <i>TERT</i> -Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
31
Citations
31
References
2020
Year
OTX015 and carfilzomib combination therapy is likely to be translated into the first clinical trial of a targeted therapy in patients with <i>TERT</i>-rearranged neuroblastoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1